CANB - Can B Corp
Region: US
Website: https://canbiola.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
canbiola, inc. (otcqb: canb) is a developer, manufacturer and seller of a variety of cannabidiol (hemp) based products such as oils, creams, moisturizers, chews,, isolate, gel caps, and concentrates. canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the cbd and the medical cannabis industry. cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure cbd products are legal in all 50 states. hemp cbd is the non-psychoactive component (no thc) used for treatment of pain, inflammation, and wellness programs. for more information about canbiola, inc., please visit: https://canbiola.com. additionally, canbiola’s wholly owned subsidiary pure health products, based in lacey, wa, is its prime development laboratory and production facility. canbiola’s duramed division has recently rolled out a durable medical device via its doctor network to treat pati